{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Angiogenesis", "Natural compounds", "Plants", "Therapy"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27154020", "DateCompleted": {"Year": "2018", "Month": "01", "Day": "29"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "05", "Day": "06"}], "ELocationID": ["10.1007/s10456-016-9512-y"], "Language": ["eng"], "Journal": {"ISSN": "1573-7209", "JournalIssue": {"Volume": "19", "Issue": "3", "PubDate": {"Year": "2016", "Month": "Jul"}}, "Title": "Angiogenesis", "ISOAbbreviation": "Angiogenesis"}, "ArticleTitle": "Plants and their active compounds: natural molecules to target angiogenesis.", "Pagination": {"StartPage": "287", "EndPage": "295", "MedlinePgn": "287-95"}, "Abstract": {"AbstractText": ["Angiogenesis, or new blood vessel formation, is an important process in the pathogenesis of several diseases and thus has been targeted for the prevention and treatment for many disorders. However, the anti-angiogenic agents that are currently in use are mainly synthetic compounds and humanized monoclonal antibodies, which are either expensive or toxic, thereby limiting their use in many patients. Therefore, it is necessary to identify less toxic, inexpensive, novel and effective anti-angiogenic molecules. Several studies have indicated that natural plant products can meet these criteria. In this review, we discuss the anti-angiogenic properties of natural compounds isolated from plants and the molecular mechanisms by which these molecules act. Finally, we summarize the advantages of using plant products as anti-angiogenic agents. Compared with currently available anti-angiogenic drugs, plant products may not only have similar therapeutic potential but are also inexpensive, less toxic, and easy to administer. However, novel and effective strategies are necessary to improve their bioavailability for clinical use."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, Ohio State University, Columbus, OH, 43210, USA."}], "LastName": "Lu", "ForeName": "Kai", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, Ohio State University, Columbus, OH, 43210, USA."}], "LastName": "Bhat", "ForeName": "Madhavi", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, Ohio State University, Columbus, OH, 43210, USA. sujit.basu@osumc.edu."}, {"Identifier": [], "Affiliation": "Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, 43210, USA. sujit.basu@osumc.edu."}], "LastName": "Basu", "ForeName": "Sujit", "Initials": "S"}], "GrantList": [{"GrantID": "R01 CA169158", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "R01 DK098045", "Acronym": "DK", "Agency": "NIDDK NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Review", "Research Support, N.I.H., Extramural"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Angiogenesis", "NlmUniqueID": "9814575", "ISSNLinking": "0969-6970"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Angiogenesis Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Polyphenols"}, {"RegistryNumber": "0", "NameOfSubstance": "Tannins"}, {"RegistryNumber": "0", "NameOfSubstance": "Terpenes"}], "MeshHeadingList": [{"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Alkaloids"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Angiogenesis Inhibitors"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Biological Products"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["blood supply", "drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neovascularization, Pathologic"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Polyphenols"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Tannins"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Terpenes"}], "CoiStatement": "Compliance with ethical standards. Conflict of interest. The authors declare that they have no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Risau W. Mechanisms of angiogenesis. Nature. 1997;386(6626):671\u2013674.", "ArticleIdList": ["9109485"]}, {"Citation": "Chung AS, Ferrara N. Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol. 2011;27:563\u2013584.", "ArticleIdList": ["21756109"]}, {"Citation": "Paleolog EM. Angiogenesis in rheumatoid arthritis. Arthritis Res. 2002;4(Suppl 3):S81\u201390.", "ArticleIdList": ["PMC3240151", "12110126"]}, {"Citation": "Heidenreich R, Rocken M, Ghoreschi K. Angiogenesis drives psoriasis pathogenesis. Int J Exp Pathol. 2009;90(3):232\u2013248.", "ArticleIdList": ["PMC2697548", "19563608"]}, {"Citation": "Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature. 2005;438(7070):967\u2013974.", "ArticleIdList": ["16355214"]}, {"Citation": "Folkman J. Fighting cancer by attacking its blood supply. Sci Am. 1996;275(3):150\u2013154.", "ArticleIdList": ["8701285"]}, {"Citation": "Al-Husein B, Abdalla M, Trepte M, Deremer DL, Somanath PR. Antiangiogenic therapy for cancer: an update. Pharmacotherapy. 2012;32(12):1095\u20131111.", "ArticleIdList": ["PMC3555403", "23208836"]}, {"Citation": "Kubota Y. Tumor angiogenesis and anti-angiogenic therapy. Keio J Med. 2012;61(2):47\u201356.", "ArticleIdList": ["22760023"]}, {"Citation": "Elice F, Rodeghiero F. Side effects of anti-angiogenic drugs. Thromb Res. 2012;129(Suppl 1):S50\u201353.", "ArticleIdList": ["22682133"]}, {"Citation": "Samant RS, Shevde LA. Recent advances in anti-angiogenic therapy of cancer. Oncotarget. 2011;2(3):122\u2013134.", "ArticleIdList": ["PMC3260813", "21399234"]}, {"Citation": "Recio MC, Andujar I, Rios JL. Anti-inflammatory agents from plants: progress and potential. Curr Med Chem. 2012;19(14):2088\u20132103.", "ArticleIdList": ["22414101"]}, {"Citation": "Tewtrakul S, Subhadhirasakul S. Anti-allergic activity of some selected plants in the Zingiberaceae family. J Ethnopharmacol. 2007;109(3):535\u2013538.", "ArticleIdList": ["16978816"]}, {"Citation": "Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev. 1999;12(4):564\u2013582.", "ArticleIdList": ["PMC88925", "10515903"]}, {"Citation": "Sagar SM, Yance D, Wong RK. Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1. Curr Oncol. 2006;13(1):14\u201326.", "ArticleIdList": ["PMC1891166", "17576437"]}, {"Citation": "Wen W, Lu J, Zhang K, Chen S. Grape seed extract inhibits angiogenesis via suppression of the vascular endothelial growth factor receptor signaling pathway. Cancer Prev Res (Phila) 2008;1(7):554\u2013561.", "ArticleIdList": ["PMC2802543", "19139005"]}, {"Citation": "Lu K, Chakroborty D, Sarkar C, Lu T, Xie Z, Liu Z, Basu S. Triphala and its active constituent chebulinic acid are natural inhibitors of vascular endothelial growth factor-a mediated angiogenesis. PLoS One. 2012;7(8):e43934.", "ArticleIdList": ["PMC3427174", "22937129"]}, {"Citation": "Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003;9(6):653\u2013660.", "ArticleIdList": ["12778163"]}, {"Citation": "Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407(6801):249\u2013257.", "ArticleIdList": ["11001068"]}, {"Citation": "Nishida N, Yano H, Nishida T, Kamura T, Kojiro M. Angiogenesis in cancer. Vasc Health Risk Manag. 2006;2(3):213\u2013219.", "ArticleIdList": ["PMC1993983", "17326328"]}, {"Citation": "Adair TH, Montani JP. Integrated Systems Physiology: from Molecule to Function to Disease. San Rafael (CA): 2010. Angiogenesis."}, {"Citation": "Gupta K, Zhang J. Angiogenesis: a curse or cure? Postgrad Med J. 2005;81(954):236\u2013242.", "ArticleIdList": ["PMC1743249", "15811887"]}, {"Citation": "Bouis D, Kusumanto Y, Meijer C, Mulder NH, Hospers GA. A review on pro- and anti-angiogenic factors as targets of clinical intervention. Pharmacol Res. 2006;53(2):89\u2013103.", "ArticleIdList": ["16321545"]}, {"Citation": "Nyberg P, Xie L, Kalluri R. Endogenous inhibitors of angiogenesis. Cancer Res. 2005;65(10):3967\u20133979.", "ArticleIdList": ["15899784"]}, {"Citation": "Folkman J, Klagsbrun M. Angiogenic factors. Science. 1987;235(4787):442\u2013447.", "ArticleIdList": ["2432664"]}, {"Citation": "Nissim Ben Efraim AH, Levi-Schaffer F. Roles of eosinophils in the modulation of angiogenesis. Chem Immunol Allergy. 2014;99:138\u2013154.", "ArticleIdList": ["24217607"]}, {"Citation": "Riabov V, Gudima A, Wang N, Mickley A, Orekhov A, Kzhyshkowska J. Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis. Front Physiol. 2014;5:75.", "ArticleIdList": ["PMC3942647", "24634660"]}, {"Citation": "Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev. 2004;56(4):549\u2013580.", "ArticleIdList": ["15602010"]}, {"Citation": "Weis SM, Cheresh DA. Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med. 2011;17(11):1359\u20131370.", "ArticleIdList": ["22064426"]}, {"Citation": "Solomon SD, Lindsley K, Vedula SS, Krzystolik MG, Hawkins BS. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2014;8:CD005139.", "ArticleIdList": ["PMC4270425", "25170575"]}, {"Citation": "Hefner L, Gerding H. Intravitreal anti-VEGF treatment of choroidal neovascularization (CNV) in pathological myopia (PM): a review. Klin Monbl Augenheilkd. 2014;231(4):414\u2013417.", "ArticleIdList": ["24771180"]}, {"Citation": "Marinaccio C, Nico B, Maiorano E, Specchia G, Ribatti D. Insights in Hodgkin Lymphoma angiogenesis. Leuk Res. 2014;38(8):857\u2013861.", "ArticleIdList": ["24957412"]}, {"Citation": "Arevalo JF. Diabetic macular edema: changing treatment paradigms. Curr Opin Ophthalmol. 2014;25(6):502\u2013507.", "ArticleIdList": ["25211039"]}, {"Citation": "Bandello F, Casalino G, Loewenstein A, Goldstein M, Pelayes D, Battaglia Parodi M. Pharmacological approach to diabetic macular edema. Ophthalmic Res. 2014;51(2):88\u201395.", "ArticleIdList": ["24356667"]}, {"Citation": "Olivieri D, Chetta A. Therapeutic perspectives in vascular remodeling in asthma and chronic obstructive pulmonary disease. Chem Immunol Allergy. 2014;99:216\u2013225.", "ArticleIdList": ["24217612"]}, {"Citation": "Lockhart AC, Rothenberg ML, Dupont J, Cooper W, Chevalier P, Sternas L, Buzenet G, Koehler E, Sosman JA, Schwartz LH, Gultekin DH, Koutcher JA, Donnelly EF, Andal R, Dancy I, Spriggs DR, Tew WP. Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumors. J Clin Oncol. 2010;28(2):207\u2013214.", "ArticleIdList": ["PMC2815710", "19949018"]}, {"Citation": "Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, Simons JW, Semenza GL. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 2000;60(6):1541\u20131545.", "ArticleIdList": ["10749120"]}, {"Citation": "Mabjeesh NJ, Post DE, Willard MT, Kaur B, Van Meir EG, Simons JW, Zhong H. Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells. Cancer Res. 2002;62(9):2478\u20132482.", "ArticleIdList": ["11980636"]}, {"Citation": "Faruque LI, Lin M, Battistella M, Wiebe N, Reiman T, Hemmelgarn B, Thomas C, Tonelli M. Systematic review of the risk of adverse outcomes associated with vascular endothelial growth factor inhibitors for the treatment of cancer. PLoS One. 2014;9(7):e101145.", "ArticleIdList": ["PMC4079504", "24988441"]}, {"Citation": "Thulliez M, Angoulvant D, Le Lez ML, Jonville-Bera AP, Pisella PJ, Gueyffier F, Bejan-Angoulvant T. Cardiovascular events and bleeding risk associated with intravitreal antivascular endothelial growth factor monoclonal antibodies: systematic review and meta-analysis. JAMA Ophthalmol. 2014;132(11):1317\u20131326.", "ArticleIdList": ["25058694"]}, {"Citation": "SooHoo JR, Seibold LK, Kahook MY. The link between intravitreal antivascular endothelial growth factor injections and glaucoma. Curr Opin Ophthalmol. 2014;25(2):127\u2013133.", "ArticleIdList": ["24406814"]}, {"Citation": "Ishak RS, Aad SA, Kyei A, Farhat FS. Cutaneous manifestations of anti-angiogenic therapy in oncology: Review with focus on VEGF inhibitors. Crit Rev Oncol Hematol. 2014;90(2):152\u2013164.", "ArticleIdList": ["24355408"]}, {"Citation": "Wang Z, Dabrosin C, Yin X, Fuster MM, Arreola A, Rathmell WK, Generali D, Nagaraju GP, El-Rayes B, Ribatti D, Chen YC, Honoki K, Fujii H, Georgakilas AG, Nowsheen S, Amedei A, Niccolai E, Amin A, Ashraf SS, Helferich B, Yang X, Guha G, Bhakta D, Ciriolo MR, Aquilano K, Chen S, Halicka D, Mohammed SI, Azmi AS, Bilsland A, Keith WN, Jensen LD. Broad targeting of angiogenesis for cancer prevention and therapy. Semin Cancer Biol. 2015;35(Suppl):S224\u2013243.", "ArticleIdList": ["PMC4737670", "25600295"]}, {"Citation": "Liu RH. Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am J Clin Nutr. 2003;78(3 Suppl):517S\u2013520S.", "ArticleIdList": ["12936943"]}, {"Citation": "Huang WY, Cai YZ, Zhang Y. Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention. Nutr Cancer. 2010;62(1):1\u201320.", "ArticleIdList": ["20043255"]}, {"Citation": "Sak K. Chemotherapy and dietary phytochemical agents. Chemother Res Pract. 2012;2012:282570.", "ArticleIdList": ["PMC3539428", "23320169"]}, {"Citation": "Wang CZ, Luo X, Zhang B, Song WX, Ni M, Mehendale S, Xie JT, Aung HH, He TC, Yuan CS. Notoginseng enhances anti-cancer effect of 5-fluorouracil on human colorectal cancer cells. Cancer Chemother Pharmacol. 2007;60(1):69\u201379.", "ArticleIdList": ["PMC2657471", "17009031"]}, {"Citation": "Sugiyama T, Sadzuka Y. Enhancing effects of green tea components on the antitumor activity of adriamycin against M5076 ovarian sarcoma. Cancer Lett. 1998;133(1):19\u201326.", "ArticleIdList": ["9929156"]}, {"Citation": "Manach C, Scalbert A, Morand C, Remesy C, Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr. 2004;79(5):727\u2013747.", "ArticleIdList": ["15113710"]}, {"Citation": "Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H, Wahala K, Montesano R, Schweigerer L. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res. 1997;57(14):2916\u20132921.", "ArticleIdList": ["9230201"]}, {"Citation": "Fotsis T, Pepper M, Adlercreutz H, Hase T, Montesano R, Schweigerer L. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr. 1995;125(3 Suppl):790S\u2013797S.", "ArticleIdList": ["7533831"]}, {"Citation": "Brakenhielm E, Cao R, Cao Y. Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J. 2001;15(10):1798\u20131800.", "ArticleIdList": ["11481234"]}, {"Citation": "Cao Z, Fang J, Xia C, Shi X, Jiang BH. trans-3,4,5\u2032-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells. Clin Cancer Res. 2004;10(15):5253\u20135263.", "ArticleIdList": ["15297429"]}, {"Citation": "Jeong SK, Yang K, Park YS, Choi YJ, Oh SJ, Lee CW, Lee KY, Jeong MH, Jo WS. Interferon gamma induced by resveratrol analog, HS-1793, reverses the properties of tumor associated macrophages. Int Immunopharmacol. 2014;22(2):303\u2013310.", "ArticleIdList": ["25042796"]}, {"Citation": "Sartippour MR, Shao ZM, Heber D, Beatty P, Zhang L, Liu C, Ellis L, Liu W, Go VL, Brooks MN. Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. J Nutr. 2002;132(8):2307\u20132311.", "ArticleIdList": ["12163680"]}, {"Citation": "Masuda M, Suzui M, Lim JT, Deguchi A, Soh JW, Weinstein IB. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. J Exp Ther Oncol. 2002;2(6):350\u2013359.", "ArticleIdList": ["12440226"]}, {"Citation": "Jung YD, Kim MS, Shin BA, Chay KO, Ahn BW, Liu W, Bucana CD, Gallick GE, Ellis LM. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br J Cancer. 2001;84(6):844\u2013850.", "ArticleIdList": ["PMC2363808", "11259102"]}, {"Citation": "Jang JY, Lee JK, Jeon YK, Kim CW. Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization. BMC Cancer. 2013;13:421.", "ArticleIdList": ["PMC3848851", "24044575"]}, {"Citation": "Don\u00e0 M, Dell\u2019Aica I, Calabrese F, Benelli R, Morini M, Albini A, Garbisa S. Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J Immunol. 2003;170(8):4335\u20134341.", "ArticleIdList": ["12682270"]}, {"Citation": "Naksuriya O, Okonogi S, Schiffelers RM, Hennink WE. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials. 2014;35(10):3365\u20133383.", "ArticleIdList": ["24439402"]}, {"Citation": "Aggarwal BB, Gupta SC, Sung B. Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. Br J Pharmacol. 2013;169(8):1672\u20131692.", "ArticleIdList": ["PMC3753829", "23425071"]}, {"Citation": "Arbiser JL, Klauber N, Rohan R, van Leeuwen R, Huang MT, Fisher C, Flynn E, Byers HR. Curcumin is an in vivo inhibitor of angiogenesis. Mol Med. 1998;4(6):376\u2013383.", "ArticleIdList": ["PMC2230271", "10780880"]}, {"Citation": "Yoysungnoen P, Wirachwong P, Bhattarakosol P, Niimi H, Patumraj S. Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice. Clin Hemorheol Microcirc. 2006;34(1\u20132):109\u2013115.", "ArticleIdList": ["16543625"]}, {"Citation": "Zhang X, Tian W, Cai X, Wang X, Dang W, Tang H, Cao H, Wang L, Chen T. Hydrazinocurcumin Encapsuled nanoparticles \u201cre-educate\u201d tumor-associated macrophages and exhibit anti-tumor effects on breast cancer following STAT3 suppression. PLoS One. 2013;8(6):e65896.", "ArticleIdList": ["PMC3692525", "23825527"]}, {"Citation": "Chen F, Guo N, Cao G, Zhou J, Yuan Z. Molecular analysis of curcumin-induced polarization of murine RAW264.7 macrophages. J Cardiovasc Pharmacol. 2014;63(6):544\u2013552.", "ArticleIdList": ["24709638"]}, {"Citation": "Gao S, Zhou J, Liu N, Wang L, Gao Q, Wu Y, Zhao Q, Liu P, Wang S, Liu Y, Guo N, Shen Y, Wu Y, Yuan Z. Curcumin induces M2 macrophage polarization by secretion IL-4 and/or IL-13. Mol Cell Cardiol. 2015;85:131\u2013139.", "ArticleIdList": ["25944087"]}, {"Citation": "Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, Schweigerer L. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci U S A. 1993;90(7):2690\u20132694.", "ArticleIdList": ["PMC46161", "7681986"]}, {"Citation": "Koroma BM, de Juan E., Jr Phosphotyrosine inhibition and control of vascular endothelial cell proliferation by genistein. Biochem Pharmacol. 1994;48(4):809\u2013818.", "ArticleIdList": ["7521641"]}, {"Citation": "Jiang C, Agarwal R, Lu J. Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin: inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells. Biochem Biophys Res Commun. 2000;276(1):371\u2013378.", "ArticleIdList": ["11006131"]}, {"Citation": "Singh RP, Sharma G, Dhanalakshmi S, Agarwal C, Agarwal R. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis. Cancer Epidemiol Biomarkers Prev. 2003;12(9):933\u2013939.", "ArticleIdList": ["14504208"]}, {"Citation": "Tyagi A, Singh RP, Ramasamy K, Raina K, Redente EF, Dwyer-Nield LD, Radcliffe RA, Malkinson AM, Agarwal R. Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophage-associated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3. Cancer Prev Res (Phila) 2009;2(1):74\u201383.", "ArticleIdList": ["PMC2615181", "19139021"]}, {"Citation": "Pili R, Chang J, Partis RA, Mueller RA, Chrest FJ, Passaniti A. The alpha-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth. Cancer Res. 1995;55(13):2920\u20132926.", "ArticleIdList": ["7540952"]}, {"Citation": "Eun JP, Koh GY. Suppression of angiogenesis by the plant alkaloid, sanguinarine. Biochem Biophys Res Commun. 2004;317(2):618\u2013624.", "ArticleIdList": ["15063803"]}, {"Citation": "Saraswati S, Agrawal SS. Brucine, an indole alkaloid from Strychnos nux-vomica attenuates VEGF-induced angiogenesis via inhibiting VEGFR2 signaling pathway in vitro and in vivo. Cancer Lett. 2013;332(1):83\u201393.", "ArticleIdList": ["23348691"]}, {"Citation": "Kim GD, Cheong OJ, Bae SY, Shin J, Lee SK. 6\u2033-Debromohamacanthin A, a bis (indole) alkaloid, inhibits angiogenesis by targeting the VEGFR2-mediated PI3K/AKT/mTOR signaling pathways. Mar Drugs. 2013;11(4):1087\u20131103.", "ArticleIdList": ["PMC3705390", "23549281"]}, {"Citation": "Saraswati S, Kanaujia PK, Kumar S, Kumar R, Alhaider AA. Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2-mediated angiogenesis. Mol Cancer. 2013;12:82.", "ArticleIdList": ["PMC3733984", "23895055"]}, {"Citation": "Lu Q, Lu S, Gao X, Luo Y, Tong B, Wei Z, Lu T, Xia Y, Chou G, Wang Z, Dai Y. Norisoboldine, an alkaloid compound isolated from Radix Linderae, inhibits synovial angiogenesis in adjuvant-induced arthritis rats by moderating Notch1 pathway-related endothelial tip cell phenotype. Exp Biol Med (Maywood) 2012;237(8):919\u2013932.", "ArticleIdList": ["22875342"]}, {"Citation": "Stafford SJ, Schwimer J, Anthony CT, Thomson JL, Wang YZ, Woltering EA. Colchicine and 2-methoxyestradiol Inhibit Human Angiogenesis. J Surg Res. 2005;125(1):104\u2013108.", "ArticleIdList": ["15836858"]}, {"Citation": "Albertsson P, Lennernas B, Norrby K. Dose effects of continuous vinblastine chemotherapy on mammalian angiogenesis mediated by VEGF-A. Acta Oncol. 2008;47(2):293\u2013300.", "ArticleIdList": ["18210302"]}, {"Citation": "Mochizuki M, Yoo YC, Matsuzawa K, Sato K, Saiki I, Tono-oka S, Samukawa K, Azuma I. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng. Biol Pharm Bull. 1995;18(9):1197\u20131202.", "ArticleIdList": ["8845804"]}, {"Citation": "Sato K, Mochizuki M, Saiki I, Yoo YC, Samukawa K, Azuma I. Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. Biol Pharm Bull. 1994;17(5):635\u2013639.", "ArticleIdList": ["7522731"]}, {"Citation": "Morisaki N, Watanabe S, Tezuka M, Zenibayashi M, Shiina R, Koyama N, Kanzaki T, Saito Y. Mechanism of angiogenic effects of saponin from ginseng Radix rubra in human umbilical vein endothelial cells. Br J Pharmacol. 1995;115(7):1188\u20131193.", "ArticleIdList": ["PMC1908790", "7582543"]}, {"Citation": "Foa R, Norton L, Seidman AD. Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity. Int J Clin Lab Res. 1994;24(1):6\u201314.", "ArticleIdList": ["7910054"]}, {"Citation": "Escuin D, Kline ER, Giannakakou P. Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1alpha accumulation and activity by disrupting microtubule function. Cancer Res. 2005;65(19):9021\u20139028.", "ArticleIdList": ["PMC6623969", "16204076"]}, {"Citation": "Lu K, Basu S. The natural compound chebulagic acid inhibits vascular endothelial growth factor A mediated regulation of endothelial cell functions. Sci Rep. 2015;5:9642.", "ArticleIdList": ["PMC4819393", "25859636"]}, {"Citation": "Chatterjee S, Bhattacharjee B. Use of natural molecules as anti-angiogenic inhibitors for vascular endothelial growth factor receptor. Bioinformation. 2012;8(25):1249\u20131254.", "ArticleIdList": ["PMC3532009", "23275729"]}, {"Citation": "Siddiqui IA, Adhami VM, Bharali DJ, Hafeez BB, Asim M, Khwaja SI, Ahmad N, Cui H, Mousa SA, Mukhtar H. Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res. 2009;69(5):1712\u20131716.", "ArticleIdList": ["PMC2950093", "19223530"]}, {"Citation": "Wang L, Li H, Wang S, Liu R, Wu Z, Wang C, Wang Y, Chen M. Enhancing the antitumor activity of berberine hydrochloride by solid lipid nanoparticle encapsulation. AAPS PharmSciTech. 2014;15(4):834\u2013844.", "ArticleIdList": ["PMC4113611", "24696391"]}, {"Citation": "Luo H, Jiang B, Li B, Li Z, Jiang BH, Chen YC. Kaempferol nanoparticles achieve strong and selective inhibition of ovarian cancer cell viability. Int J Nanomedicine. 2012;7:3951\u20133959.", "ArticleIdList": ["PMC3410694", "22866004"]}, {"Citation": "Gou M, Men K, Shi H, Xiang M, Zhang J, Song J, Long J, Wan Y, Luo F, Zhao X, Qian Z. Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale. 2011;3(4):1558\u20131567.", "ArticleIdList": ["21283869"]}, {"Citation": "Saha SK, Khuda-Bukhsh AR. Molecular approaches towards development of purified natural products and their structurally known derivatives as efficient anti-cancer drugs: current trends. Eur J Pharmacol. 2013;714(1\u20133):239\u2013248.", "ArticleIdList": ["23819913"]}, {"Citation": "Mori M, Supuran CT. Editorial: Challenging Organic Syntheses and Pharmacological Applications of Natural Products and their Derivatives. Curr Pharm Des. 2015;21(38):5451\u20135452.", "ArticleIdList": ["26573007"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "12", "Day": "21"}, {"Year": "2016", "Month": "5", "Day": "1"}, {"Year": "2016", "Month": "5", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "5", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "1", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "7", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27154020", "NIHMS792672", "PMC4930694", "10.1007/s10456-016-9512-y", "10.1007/s10456-016-9512-y"]}}], "PubmedBookArticle": []}